Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the ...

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

Escalating trade tensions in 2025 led to significant tariffs on imports, affecting the pharmaceutical supply chain and prompting domestic manufacturing investments. Major pharmaceutical companies, ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

Henan Medinno Pharmaceutical Technology Co. Ltd. has synthesized TGF-β receptor type-1 (TGFBR1; ALK5; SKR4; TβR-I) inhibitors reported to be useful for the treatment of cancer, aging, arteriosclerosis ...

@2024 - All Right Reserved.

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Beijing Danatlas Pharmaceutical Technology Co. Ltd. has identified thiadiazolyl derivatives acting as DNA polymerase θ (POLθ, POLQ) inhibitors reported to be useful for the treatment of cancer.

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...